New Drugs for the Veterinary Patient: How They Work and Their Clinical Effects (1119)
Companion Animal Medicine |  Anesthesiology/Pain Management
Sunday |  9:00 AM -  9:50 AM
Henry B. Gonzalez Convention Center||303

 

Speaker(s)

Jane Quandt DVM, MS
University of Georgia

Jane Quandt graduated from Iowa State University in 1987 with her DVM. She completed her residency and Masters in Anesthesia from the University of Minnesota in 1991. She did second residency in small animal emergency and critical care from University of California at Davis. Dr. Quandt is double boarded in anesthesia and emergency and critical care. She is a faculty member at the University of Georgia College of Veterinary Medicine. Dr. Quandt enjoys riding and running in her spare time and has completed several half marathons.

Presentation Info

CE Credit(s): 1.00
CE Level: 1

Description

This lecture will cover the mechanism of action and clinical effects of drugs recently introduced to the veterinary market. The drugs that will be discussed are: propofol 28, recuvyra, remifentanil, simbadol (long acting buprenorphine for cats), and aflaxalone. The clinical use of these drugs will be discussed using clinical cases (dogs and cats)

Learning Objectives

1. Understanding how these new drugs work and their potential side effects

2. When these drugs can be used clinically and what to expect

Convention Notes

Convention notes require you to log in. Please click here to login